FDA ta amince da Restylane Defyne don haɓakar jaw

Galderma ya ba da sanarwar cewa FDA ta amince da Restylane Defyne, mai filler HA, don haɓaka chin.
Kamfanin kyau da magunguna na Galderma kwanan nan ya sanar da cewa FDA ta amince da Restylane Defyne don haɓakawa da gyara koma bayan chin mai laushi zuwa matsakaici a cikin manya sama da shekaru 21.
Restylane Defyne, wanda aka fara yarda dashi a cikin 2016, shine hyaluronic acid (HA) dermal filler wanda aka fara amfani dashi don matsakaici zuwa zurfin allura a cikin kyallen fuska don magance matsakaici zuwa matsananciyar wrinkles da folds na fuska.
Galderma yana amfani da fasahar kera na musamman na XpresHAN, wanda aka sani a duniya azaman Fasahar Balance Mafi Kyau (OBT), don ƙirƙirar gel ɗin injectable mai santsi wanda zai iya haɗawa cikin fata cikin sauƙi don motsi na halitta da ƙarfi.
"Wannan shine karo na 8 da Galderma ya sami amincewar FDA a cikin shekaru 5, kuma yana nuna cewa muna da dogon lokaci don inganta kayan ado ta hanyar sababbin sababbin abubuwa," in ji Alisa Lask, babban manajan kuma mataimakin shugaban kasuwancin Galderma na Amurka. a cikin sanarwar manema labarai da ke sanar da amincewa.“Gashi ita ce tushen fuska kuma tana iya daidaita sauran halayen ku.Masu amfani yanzu za su iya amfani da marasa tiyata, zaɓuɓɓuka masu aminci don magance matsalolin chin.Alamar tana amfani da fasahar XpresHAN mai yanke hukunci don tsarawa da samar da sakamako mai dorewa."
An sami amincewar Restylane Defyne bayan bayanai daga maɓalli na gwaji na asibiti na Mataki na 3 wanda ke goyan bayan amincin sa da juriya a haɓakar jaw.Daga cikin marasa lafiya a cikin binciken, 86% ba su fuskanci wani mummunan al'amuran da suka shafi jiyya ba, kuma kawai wani matsakaicin matsakaici na ciwon wurin allura.
Kashi casa'in da tara na marasa lafiya sun ba da rahoton samun ci gaba a cikin bayyanar chin da ke fitowa (lokacin da aka tambaye shi a cikin makonni 12), kuma kashi 96% na masu yin allurar sun bayyana cewa maganin ya inganta bayyanar chin har zuwa shekara guda.
Gwajin ya nuna cewa kashi 74 cikin 100 na marasa lafiya sun samu gagarumin ci gaba a hasashen chin a tsawon shekara guda, idan aka kwatanta da kashi 86% a makonni 12.Ana auna wannan ta amfani da sikelin ja da baya na Gartner (GCRS).Sakamakon kyawawa bayan jiyya yana da inganci kuma an nuna su ta hanyar babban matakin gamsuwa a cikin FACE-Q da Tambayoyin Inganta Ƙwallon Ƙwallon Duniya (GAIS).
“Majiyyata sau da yawa suna zuwa wurina don yin tambaya game da sabbin hanyoyin magani don ci gaba da kula da yanayinsu mafi kyau.Mutane da yawa suna mamakin lokacin da na bayyana tasirin haɓakar muƙamuƙi da ma'auni na ƙananan fuska shine mabuɗin don taimakawa wajen samun cikakkiyar kyawun fuska," Anne Chapas, MD, ƙwararren likitan fata da likitan fata a New York, kuma mai bincike don Restylane Defyne Chin gwajin asibiti, ya ce a cikin wata sanarwa da aka fitar."Kasan fuskar fuska koyaushe tana motsi, don haka yana da mahimmanci ga marasa lafiya su zaɓi abubuwan da suka dace kamar Restylane Defyne, waɗanda aka haɓaka ta hanyar kimiyya don dacewa da yanayin fuskar su."